Introduction
Oral route is the most preferable and convenient route of administration as it offers advantages like ease of administration, highly versatile, patient compliance and accurate dosing [1] . The most popular solid dosage forms are being tablets and capsules. One important drawback of these dosage forms for some patients, is the difficulty to swallow and readily access to water for easy swallowing dosage [2] . Difficulty in swallowing (dysphasia) is also a common problem of all age groups, especially the elderly and paediatrics, because of physiological changes associated with these groups [3] . Fast dissolving drug delivery is rapidly gaining acceptance as an important new drug delivery technology which aims to enhance safety and efficacy of drug molecule by formulating a convenient dosage form for administration and to achieve better patient compliance [4] . The fast dissolving tablet (FDT) has remarkable disintegration properties and it can rapidly disintegrate without water in the mouth within few seconds. When an FDT is placed in the oral cavity, saliva quickly penetrates into the pores causing rapid disintegration [5] . Based on the absolute bioavailability of diclofenac sodium [6] , tablet is about 50-60%. The half-life is 2 h and highly protein
A R T I C L E I N F O A B S T R A C T
Objective: To formulate diclofenac sodium as fast dissolving tablets (FDTs) using fenugreek gum as a natural superdisintegrant which also possess anti-inflammatory activity.
Methods: An attempt was made to extract the fenugreek gum and evaluated it for various physicochemical characterizations. The swelling index and viscosity of fenugreek gum was 221% and 293.4 mpa.s respectively. FDTs of diclofenac sodium was formulated by direct compression technique using different concentrations (1%-6%, w/w) of fenugreek gum as a natural superdisintegrant and compared with renowned synthetic superdisintegrants like sodium starch glycolate and croscarmellose sodium. The anti-inflammatory activity of a formulation was evaluated with carrageenan induced experimental rats.
Results: The formulated tablets were evaluated for various physical tests like weight variation, friability, hardness and results complied with the limits. The drug release from all the formulations ascertained first order kinetics. Among all the formulations F3 containing fenugreek gum with the concentration of 6% produced least disintegrating time 21 seconds resulting in higher drug release rate 93.74% at the end of 25 min. Hence, it was considered as optimized formulation. The present study revealed that the fenugreek gum as a natural superdisintegrant showed better disintegrating property than the most widely used synthetic superdisintegrants like sodium starch glycolate and croscarmellose sodium in the formulations of FDTs.
Conclusions:
The results suggested that the fenugreek gum act as a good super disintegrating agent and it showed promising additive anti-inflammatory activity with diclofenac sodium.
bound (>99%). In the bioavailability classification system, diclofenac is classified as a class II drug, because of its low water solubility and high permeability. The bioavailability of drug is significantly greater than those observed from conventional tablet dosage form. Usually, superdisintegrants are added to a drug formulation to facilitate the break-up or disintegration of tablet or capsule content into smaller particles that can dissolve more rapidly than drugs in the absence of disintegrates. Many superdisintegrants like cross povidone, croscarmellose sodium (Ac-di-sol) and sodium starch glycolate (SSG) have been used in the formulations of FDTs. In the present study it was proposed to formulate an oral drug delivery, in the form of FDTs by using direct compression method [7] . The purpose of the present study was to extract the fenugreek gum, evaluate its powder flow properties (bulk density, tapped density, angle of repose, Carr's index and hausner ratio), swelling index and loss on drying and to compare disintegration efficiency of fenugreek gum with widely used synthetic superdisintegrants i.e. SSG and croscarmellose sodium in the formulation of FDTs. All the superdisintegrants were used in optimized concentration levels to assess their efficiency. The tablets were evaluated in various physical tests. The formulation of a FDTs, thus containing diclofenac sodium and fenugreek gum, produces additive anti-inflammatory activity resulting in reduction in a dose of diclofenac sodium and thereby its dose related side effects.
Materials and methods

Materials
Fenugreek seeds, diclofenac sodium (Harman Finochem Ltd, Mumbai), microcrystalline cellulose (SD Fine Chemicals), SSG (SD Fine Chemicals), croscarmellose sodium (Arrow Chem. Product., Mumbai), hexane (SD Fine Chemicals) and all other ingredients used throughout the study were of analytical grades.
Methods
Extraction and purification of fenugreek gum
Fenugreek seed (100 g) were ground to 100 mesh using a laboratory mill. The fine powder was extracted with boiling hexane in Soxhlet apparatus for 80 min. The obtained extract was treated with 95% ethanol (maintaining its boiling point) for 130 min in a conical flask to remove the unwanted saponin. Further enzyme deactivated was initiated by refluxing the extract with 70% ethanol for 180 min. The resulting mixture was repeatedly treated with ethanol to remove undissolved traces if necessary. The residue was filtered through sintered glass at room temperature. The filtered residue was subjected to mechanical stirring at 700 r/min with addition of water for 8 h. The obtained mixture was centrifuged at 5 000 r/min for 12 min at 10 °C .
The supernatant contained crude fenugreek gum, which was decanted and precipitated by adding of ethanol (70%). Thus the gum precipitate was washed with acetone, diethyl ether and water. The pure fenugreek gum was oven dried [8] .
Physicochemical characterization of gum
The purified and dried extracted gum powder was evaluated for its micromeritic properties, viscosity, solubility studies, swelling index and loss on drying.
Swelling index
The study was carried out by using a 100 mL stoppered graduated cylinder. The initial bulk volume of 1 g of fenugreek gum was noted. Water was added in sufficient quantity to ensure 25 mL of uniform dispersion by vigorously shaking every 10 min for 1 h and then allowed to stand for 24 h. The dispersion was stored at room temperature and the sediment volume of the swollen mass was measured after 24 h [9] .
Swelling index=100伊(V 2 -V 1 /V 1 ) Where, V 1 =Initial volume of material before hydration; V 2 =Volume of hydrated material.
Viscosity
One gram of fenugreek gum powder was suspended in 75 mL of distilled water for 4 h. Distilled water was added up to 100 mL to produce the concentration of 1%. The mixture was homogenized by mechanical stirrer for 2 h and its viscosity was determined by using Brookfield viscometer, spindle SC4-18 (Brookfield Viscometer, DV-2+LV) at 5 r/ min [10] .
Loss on drying
Loss on drying technique is used to determine high levels of moisture or solvents present in the sample. The material sample was weighed (W 1 ) and heated in an oven for 2 h. It was cooled in the dry atmosphere of desiccators and then finally weighed (W 2 
. Drug-excipient compatibility studies
The physicochemical compatibility between diclofenac sodium and fenugreek gum used in the research were assessed by subjecting to infrared spectral studies. The samples were scanned under diffuse reflectance mold and the graph was plotted by KBr pellet method. Its spectra were recorded in the wavelength region between 4 000 cm -1 to 400 cm -1 . The spectra of diclofenac sodium, fenugreek gum and physical mixtures of diclofenac sodium and fenugreek gum were compared.
Formulation of FDTs
FDTs containing 50 mg diclofenac sodium were prepared by direct compression method and the formulae used in the study are shown in Table 1 . The formulation containing varying proportions (for optimization) of fenugreek gum along with the microcrystalline cellulose as direct compressible diluent and mannitol as sweetening agent. To compare disintegration efficiency of fenugreek gum with widely used synthetic superdisintegrants i.e. SSG and croscarmellose sodium. All the ingredients were passed through # 60 separately to attain uniformity and mixed thoroughly. The blended mixture was directly compressible into tablets with 9 mm punch using 16-station rotary tableting machine (Table 1 ). Talc   3  3  3  3  3  3  3  3  3 Magnesium stearate 
Evaluation of tablets
All the tablets were evaluated for different physical parameters as weight variation, hardness, friability, disintegration time, wetting time, drug content and in vitro dissolution study [11] [12] [13] .
Thickness
The thicknesses of the formulated tablets were measured by using Vernier callipers.
Weight variation
The formulated tablets were tested for weight uniformity. For this 20 tablets were weighed collectively and individually. From the collective weight, average weight was calculated. Each tablet's weight was then compared with average weight to ascertain whether it was within permissible limits or not.
% Weight variation = Average weight Average weight-Individual weight ×100
Hardness
Hardness of tablets was measured using Pfizer type hardness tester. Three tablets were selected from each formulation randomly and their hardness was measured. The mean依SD of hardness values were calculated.
Friability
Friability of the tablets was determined by using Roche friabilator. The 
Drug content
Twenty tablets were weighed and powdered. The quantity of powder equivalent to 50 mg of diclofenac sodium was dissolved in phosphate buffer pH 6.8 diluted to 100 mL with the same and the solution was filtered and suitably diluted. The drug content was estimated spectrometrically at 276 nm.
In vitro disintegration test
In vitro disintegration time was determined by using disintegration test apparatus (Electrolab, USP model ED-2L, Mumbai) without disk for six tablets. The disintegration medium was 900 mL of distilled water kept at (37.0依0.5) °C and stirred at a rate of (30依2) r/min. The time was measured in seconds for complete disintegration of the tablet with no palpable mass remaining in the apparatus. The test was carried out in triplicate.
In vitro dissolution studies
Dissolution rate was studied by using USP type II paddle dissolution apparatus, in 900 mL of phosphate buffer pH 6.8 at (37.0依0.5) °C at 75 r/min. Aliquot of dissolution medium was withdrawn at regular time intervals and the same volume of pre-warmed (37依0.5) °C fresh dissolution medium was replaced. The samples were filtered and drug content of diclofenac sodium in each sample was analyzed after suitable dilution by Shimadzu UV-spectrophotometer at 276 nm.
Pharmacodynamic studies
Pharmacodynamic study was carried out in adult male Wistar rats weighing 180-260 g obtained from the Animal House of Bapatla College of Pharmacy (1032/ac/07/CPCSEA), Bapatla [14] . The experiment protocol (IAEC/IV-9/BCOP/2012) was approved by the Institutional Animal Ethical Committee of Bapatla College of Pharmacy. Inflammation was induced in rats using Lambda carrageenan (1%) suspension. A dose of the tablets equivalent to human's body weight was dissolved in normal saline and administered orally to the rats. After 4 h the percentage of inhibition of paw volume was measured.
To study the additive anti-inflammatory activity of diclofenac sodium and the extract of fenugreek gum powder, Wistar rats (180-260 g) were divided into 4 groups, each with S332 six rats and were fasted for 18 h with free access to water. To Group I normal saline was administered and used as the negative control. For Group II, 5 mg/kg of diclofenac sodium was administered. For Group III, a physical mixture of 5 mg/kg of diclofenac sodium and 1.1 mg/kg of fenugreek gum powder was administered. Group IV received a 1.1 mg/kg fenugreek gum.
After 30 min, oedema was induced by injecting 0.1 mL of 1% carageenan suspension into the sub planter region of right hind paw rats in all groups. The volume changes in the rat paw were measured by Plethysmographic technique. The mercury volume displaced in the Plethysmographic (the paw volume) was measured at the end of 4 h.
The anti-inflammatory activity (percentage inhibition) was calculated by using the formula:
Where, A=Mean paw volume of control (left leg); B=Mean paw volume of drug treated animals (right leg).
Results
The fenugreek gum was extracted and evaluated for the physicochemical characterization as shown in Table 2 . Compatibility study of diclofenac sodium and fenugreek gum were conducted by employing infrared spectral studies as shown in Figures 1-3 . The swelling index and viscosity of fenugreek gum was 221% and 293.4 mpa.s respectively. The percent of loss on drying was observed within limit. In case of micromeritic studies such as bulk density was found to be 0.396 g/cm 3 and tapped density was 0.413 g/cm 3 . From density data percentage of Carr's index was calculated as 14.11%. Angle of repose was found to be 22.4°. Hausner's ratio was found below 1.12% indicating well acceptable limits. The different formulations of diclofenac sodium FDTs were prepared by direct compression method using fenugreek gum as a natural superdisintegrants, and were compared Table 4 Effect of anti inflammatory activity of diclofenac sodium and fenugreek gum on caragennan induced rat paw oedema. Data are expressed as mean依SEM. All values are expressed as mean依SD (n=3).
with various standard synthetic superdisintegrants like SSG, croscarmellose sodium. All the superdisintegrants were used in optimised concentration. The tablets were prepared and evaluated. Results were shown in Table 3 and Figure  4 . And the results of additive anti-inflammatory activity of diclofenac sodium and the extract of fenugreek gum powder is shown in 
Discussion
The method employed for the production of the fenugreek gum from fenugreek seeds was found to be reproducible. The characteristic peaks in the physical mixture of diclofenac sodium and fenugreek gum indicated that the gum did not interfere the peaks of drug confirming its compatibility. The physicochemical characterization adopted for the gum powder revealed that it possessed good swelling ratio in the distilled water. The rheological studies indicated that 1% w/v gum dispersion in water had a gel like consistency exhibiting pseudoplastic behaviour. The flow properties of the powder attribute to the uniform mass of the tablets which is essential prior to compression to tablets. The micromeritic properties of gum powder such as bulk density and tapped density indicated good packing characteristics. Further the Carr's index, Hausner's ratio and angle of repose were found to be 14.11%, 1.042 and 22.40° respectively indicating the desirable flow properties. The formulated FDTs were subjected to evaluation. The weight variation of all the tablet formulations complied with the pharmacopeial limits. The hardness of the FDTs was between 5.6 to 6.4 kg/cm 2 and the thickness was 3.8 to 4.3 mm. Hardness and thickness studies indicated the mechanical strength of the tablet. The percent friability was well within prescribed limits revealing the physical integrity of the tablet. The percent of drug content in all the formulated tablets was in the range of 99.28% to 99.89%, ensuring the uniformity of drug content in all the tablets. The wetting time of all the formulated tablets (F1 to F9) were found to be 17 to 51 seconds. These results suggested that the wetting process of the tablets were closely related to the inner structure of the tablets, especially pore size, which affects water penetration into the tablets. Of all the formulations, the tablets formulated with fenugreek gum (F3) showed the least wetting time of 17 seconds, which had a direct impact on high water absorption ratio (92.48依1.98)%. It was observed that the increased concentration of fenugreek gum decreased the disintegration time and optimized the drug release. Fenugreek gum in the concentration of 6% acts as a eminent superdisintegrant and disintegrates the tablet within 21 seconds fulfilling the criteria of FDT. Further the higher dissolution rate of the F3 formulation 93.74% at the end of 25 min indicated that fenugreek gum had a better choice among the renowned synthetic super disintegrating agents like SSG and croscarmellose sodium. From the data of in vivo studies, it was assumed that Group III formulation containing 5 mg/kg diclofenac sodium and 1.1 mg/kg fenugreek gum exhibited more significant inhibition comparing with the other groups include the control. This significant anti-inflammatory activity may be due to the synergistic action of diclofenac sodium and fenugreek gum resulting in the better suppression of various inflammatory mediators in prostaglandin synthesis, cytokinins production and leucocytes migration. Hence, it can be concluded that the fenugreek gum acts as a good superdisintegranting agent and shows promising additive anti-inflammatory activity with diclofenac sodium in quick relief of pain.
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